EUDA Health Holdings Limited EUDA 深 滬
等待開盤 03-26 09:30:00 美东时间
11.47
+2.340
+25.63%
華盛通- 最 高11.47
- 今 開9.17
- 成交量 1.55万股
- 最 低 9.14
- 昨 收 9.13
- 總市值 4.26亿
- 52周最高 86.00
- 市盈率 靜 --
- 換手率 0.04%
- 52周最低 6.42
- 委 比 -66.94%
- 總股本 3715.64万
- 歷史最高 210.00
- 量 比 0.09
- 振 幅 25.52%
- 歷史最低 6.538
- 每 手 1
- 風險率 21.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EUDA Announces Reverse Stock Split of its Ordinary Shares
EUDA Health Holdings Limited will implement a 1-for-20 reverse stock split effective March 23, 2026. This will reduce the number of outstanding shares from approximately 50.3 million to 2.5 million. Warrants will be adjusted to reflect the split, with the exercise price increasing from $11.50 to $230.00. Shareholders' ownership percentages remain unchanged, and those holding paper certificates may exchange them for updated ones if desired. No act...
03-19 09:30
美股大行评级 | 潜在涨幅148%！瑞银、小摩等8家大行首予SOLV Energy买入评级目标价42美元；甲骨文绩前遭德银等下调目标价；京东遭巴克莱下调目标价
今日重点评级关注：Evercore ISI集团：维持Caribou Biosciences"跑赢大市"评级，目标价从11美元升至13美元；富国银行：上调uniQure评级至"超配"，目标价从15美元升至60美元
03-10 15:05
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers AN2 Therapeutics (NASDAQ:ANTX) stock moved upwards by 94.4% to $5.54 d...
03-10 01:05
EUDA Health Acquires, Cancels Previously Announced Warrants Of Streeterville Capital For $125K
EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has repurchased and
03-04 22:13
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
EUDA Health Holdings Limited, a Singapore-based non-invasive healthcare provider, announced the full repurchase and cancellation of a warrant previously issued to Streeterville Capital, LLC. The warrant, exercisable into up to 2,000,000 ordinary shares, was repurchased for US$125,000 on February 27, 2026, eliminating the potential issuance of shares under this agreement.
03-04 14:10
EUDA Health Subsidiary Signs Loan Convertible Agreement With Shenzhen Inno Immune To Invest Up To RMB6M In Two Tranches
EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that its wholly owned
01-13 20:56
EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform
EUDA Health Holdings Limited has entered into a convertible loan agreement with Shenzhen Inno Immune Co., Ltd. Under the agreement, EUDA will invest up to RMB 6 million in two tranches to upgrade Shenzhen Inno's cGMP facility, creating a state-of-the-art production and innovation center for stem cell treatments. The investment provides EUDA with the option to convert the loan into equity in Shenzhen Inno. Shenzhen Inno operates a stem cell techno...
01-13 12:49
EUDA Health Launched Its Nationwide Stem Cell Extraction, Cryogenic Storage, And Clinical Delivery Platform In China
The Company has partnered with Shenzhen Inno Immune Co., Ltd. and Wuhan Kaien Hospital as the Company continues to expand its national clinical and logistics network. This platform marks a major step in EUDA's
2025-12-30 20:04
美股牛股 | 奥麦罗制药涨超75%，YARTEMLEA药物获得FDA批准；德纳维制药涨超38%
奥麦罗制药涨超75%，YARTEMLEA药物获得FDA批准；德纳维制药涨超38%，获法国制药巨头22亿美元收购；Sidus Space涨超33%，获美国导弹防御局合同>>
2025-12-26 18:41
EUDA Health Holdings Announces Strategic Technology Integration To Introduce QB Utility Token Into Digital Health And Rewards Platform
EUDA Health Holdings Limited (NASDAQ:EUDA) "EUDA" or "the Company", a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a strategic technology integration
2025-12-22 20:13
